-
361
Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial
Published 2025-01-01“…However, there is limited evidence for PRO-based symptom monitoring on advanced NSCLC during immunotherapy. This study proposes an electronic PRO-based symptom tracking intervention, integrated with reactive alerts and nudges (PRO-NET) to improve HRQoL for advanced NSCLC patients receiving immunotherapy in China. …”
Get full text
Article -
362
-
363
Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9
Published 2025-01-01“…The deep learning analysis using 12,159 cancer samples from 26 cancer types and 725 cancer samples from 5 immunotherapy cohorts revealed that H3K4me3-RS was significantly correlated with cancer immune tolerance and sensitivity. …”
Get full text
Article -
364
TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
365
-
366
Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study
Published 2022-06-01“…Introduction Immunotherapy is the fourth leading therapy for lung cancer following surgery, chemotherapy and radiotherapy. …”
Get full text
Article -
367
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
Published 2025-02-01Subjects: Get full text
Article -
368
Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
Published 2023-06-01Subjects: Get full text
Article -
369
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
Published 2024-03-01Subjects: Get full text
Article -
370
Deregulated methylation and expression of PCDHGB7 in patients with non-small cell lung cancer: a novel prognostic and immunological biomarker
Published 2025-01-01Subjects: Get full text
Article -
371
-
372
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
Published 2025-12-01Subjects: Get full text
Article -
373
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Published 2025-01-01Subjects: Get full text
Article -
374
Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
375
Unraveling the Anti-Cancer Mechanisms of Antibiotics: Current Insights, Controversies, and Future Perspectives
Published 2024-12-01Subjects: Get full text
Article -
376
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
Published 2025-02-01Subjects: Get full text
Article -
377
Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
378
VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1
Published 2025-02-01Subjects: “…Immunotherapy…”
Get full text
Article -
379
-
380
Two episodes of biphasic anaphylaxis in a boy allergic to wasp sting. Case report
Published 2024-09-01Subjects: “…allergen immunotherapy…”
Get full text
Article